Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREST: Influenza Vaccine for Stroke Prevention in Sickle Cell Anaemia
NCT03666806Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Aug 2018
- Primary completion
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of influenza vaccine in influenza (2 arms), sponsored by Makerere University. Primary endpoint: Incidence of stroke at 12 months. Status: unknown.
02
Drugs
influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03666806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03666806.